Mefacit en es it fr

Mefacit Brand names, Mefacit Analogs

Mefacit Brand Names Mixture

  • No information avaliable

Mefacit Chemical_Formula


Mefacit RX_link

Mefacit fda sheet

Mefacit msds (material safety sheet)

Mefacit MSDS

Mefacit Synthesis Reference

No information avaliable

Mefacit Molecular Weight

241.285 g/mol

Mefacit Melting Point

230-231 oC

Mefacit H2O Solubility

20 mg/L

Mefacit State


Mefacit LogP


Mefacit Dosage Forms

Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)

Mefacit Indication

For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.

Mefacit Pharmacology

Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.

Mefacit Absorption

Mefenamic acid is rapidly absorbed after oral administration.

Mefacit side effects and Toxicity

Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.

Mefacit Patient Information

Mefacit Organisms Affected

Humans and other mammals